Company · CIK 1851484
CITIUS ONCOLOGY, INC.
| CIK | 1851484 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | CTOR (Nasdaq) |
| First annual or quarterly report | 2022-11-28 |
Offerings
5 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-296360 | 2026-05-29 | 2026-06-05 | 2 | |
| 333-288656 | 2025-07-14 | 2026-03-02 | 5 | |
| 333-292577 | 2026-01-05 | 2026-01-12 | 2 | |
| 333-289979 | 2025-09-02 | 2025-12-10 | 4 | |
| 333-256271 | 2021-05-19 | 2022-10-14 | 11 |
Filings
27| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2026-06-05 | EFFECTDeclared effective | 333-296360 | 9999999995-26-001912 |
| 2026-05-29 | S-3Shelf registered | 333-296360 | 0001213900-26-062864 |
| 2026-03-02 | EFFECTDeclared effective | 333-288656 | 9999999995-26-000698 |
| 2026-01-12 | EFFECTDeclared effective | 333-292577 | 9999999995-26-000150 |
| 2026-01-05 | S-3Shelf registered | 333-292577 | 0001213900-26-001187 |
| 2025-12-10 | 424B5Shelf takedown | 333-289979 | 0001213900-25-119760 |
| 2025-09-10 | 424B5Shelf takedown | 333-289979 | 0001213900-25-086384 |
| 2025-09-04 | EFFECTDeclared effective | 333-289979 | 9999999995-25-002843 |
| 2025-09-02 | S-3Shelf registered | 333-289979 | 0001213900-25-082919 |
| 2025-08-20 | DRSDraft made public | 377-08347 | 0001213900-25-078919 |
| 2025-07-17 | 424B4Final prospectus | 333-288656 | 0001213900-25-064848 |
| 2025-07-16 | EFFECTDeclared effective | 333-288656 | 9999999995-25-002269 |
| 2025-07-14 | S-1/AAmendment | 333-288656 | 0001213900-25-063793 |
| 2025-07-14 | S-1Registration filed | 333-288656 | 0001213900-25-063483 |
| 2025-04-28 | DRSDraft made public | 377-07955 | 0001213900-25-036067 |
| 2024-07-12 | EFFECTDeclared effective | 333-275506 | 9999999995-24-002146 |
| 2022-10-14 | 424B4Final prospectus | 333-256271 | 0001493152-22-028441 |
| 2022-10-13 | EFFECTDeclared effective | 333-256271 | 9999999995-22-003025 |
| 2022-09-12 | S-1/AAmendment | 333-256271 | 0001493152-22-025658 |
| 2022-07-29 | S-1/AAmendment | 333-256271 | 0001493152-22-020683 |
| 2022-05-24 | S-1/AAmendment | 333-256271 | 0001493152-22-014854 |
| 2022-05-11 | S-1/AAmendment | 333-256271 | 0001493152-22-012880 |
| 2022-04-01 | S-1/AAmendment | 333-256271 | 0001493152-22-008828 |
| 2022-03-08 | S-1/AAmendment | 333-256271 | 0001493152-22-006313 |
| 2021-08-20 | S-1/AAmendment | 333-256271 | 0001493152-21-020860 |
| 2021-06-30 | S-1/AAmendment | 333-256271 | 0001493152-21-015601 |
| 2021-05-19 | S-1Registration filed | 333-256271 | 0001493152-21-012185 |